Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.
By T. Vesikari, A. Karvonen, R. Prymula, Volker Schuster, J. Tejedor, Robert Cohen, F. Meurice, H. H. Han, Silvia Damaso, A. Bouckenooghe. The Lancet, 2007
664 citations recorded by the source corpus.
Subfields: Food Science, Infectious Diseases, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/912f8e7b36ffadbc4f95976d207dede1b10741d3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Cortese
- Umesh D. Parashar
Citations in the corpus
- Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2009, background): “The efficacy of the licensed formulation of RV1 has been evaluated in two large phase III trials among healthy infants, one conducted in 11 Latin American countries (109) and one conducted in six European countries (110) (Table 1).”